Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Sono-Tek Shares Gain Post Q4 Results; Clocks 22% Sales Growth

Sono-Tek Corp (NASDAQ:SOTK) reported fourth-quarter FY22 sales growth of 22% year-on-year to $5 million. The FY22 revenue grew 15.5% Y/Y to $17.1 million. The Q4 gross margin expanded 513 bps to 51.1%. The FY22 margin grew 310 bps to 50.3%, driven by the strength in sales, increased efficiencies, and a favorable product mix.…

Benzinga

Kim Kardashian - Beyond Meat: See What's The Link Here

Beyond Meat Inc (NASDAQ:BYND) has roped in professional tastemaker and entrepreneur Kim Kardashian as its Chief Taste Consultant. Kardashian will share her favorite Beyond Meat products through the company newsletter, which will include exclusive offers, recipes, content, and more. "I've been focusing on going more plant-based and can tell you that Beyond Meat…

Benzinga

Expert Ratings for Mirati Therapeutics

Within the last quarter, Mirati Therapeutics (NASDAQ:MRTX) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

22 Analysts Have This to Say About Alphabet

Alphabet (NASDAQ:GOOGL) has observed the following analyst ratings within the last quarter:

Benzinga

Edesa Biotech Adds Mechanically Ventilated Patients To Late-Stage COVID-19 Study

Edesa Biotech Inc (NASDAQ:EDSA) has initiated enrollment for the second cohort of patients for the Phase 3 part of a Phase 2/3 study of the company's critical care drug candidate, designated EB05. Edesa is currently evaluating EB05, a monoclonal antibody, in critically ill patients with COVID-19-induced Acute Respiratory Distress Syndrome (ARDS). The company's…

Benzinga

Analyst Ratings for uniQure

Within the last quarter, uniQure (NASDAQ:QURE) has observed the following analyst ratings:

Benzinga

If You Invested $1000 In Trade Desk 5 Years Ago, Here's How Much You Would Have Today

Trade Desk (NASDAQ:TTD) has outperformed the market over the past 5 years by 41.17% on an annualized basis producing an average annual return of 51.19%. Currently, Trade Desk has a market capitalization of $20.55 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

NV5 Secures $8M In Federal, State Geospatial Projects

NV5 Global Inc (NASDAQ:NVEE) has secured $8 million in recent contracts to provide geospatial data acquisition and data analytics services to support infrastructure, utility, and natural resource assets for public sector clients. NV5 was awarded two contracts totaling more than $4 million to support the U.S. Geological Survey's 3D Elevation Program in Kentucky…

Benzinga

Guardforce AI Acquires Eight Companies In China For $30M

Guardforce AI Co Ltd (NASDAQ:GFAI) (NASDAQ:GFAIW) entered into two definitive agreements to acquire eight companies in China for $30 million. The deal will be paid in a combination of cash (10%) and restricted ordinary shares of GFAI (90%) at an agreed price of $2/share. As per the first agreement, GFAI will acquire Beijing…

Benzinga

Why Merger Talks Between Electronic Arts And NBCUniversal Failed: Who's A Potential Buyer?

Electronic Arts Inc. (NYSE: EA) shares traded higher by 1.5% on a down day in the market on Tuesday following unconfirmed media reports that EA has been aggressively pursuing a sale of the company.

Benzinga

What 15 Analyst Ratings Have To Say About Marqeta

Within the last quarter, Marqeta (NASDAQ:MQ) has observed the following analyst ratings:

Benzinga

Expert Ratings for Rhythm Pharmaceuticals

Analysts have provided the following ratings for Rhythm Pharmaceuticals (NASDAQ:RYTM) within the last quarter:

Benzinga

MoffettNathanson Maintains Buy Rating for Coinbase Global: Here's What You Need To Know

MoffettNathanson has decided to maintain its Buy rating of Coinbase Global (NASDAQ:COIN) and lower its price target from $600.00 to $200.00. Shares of Coinbase Global are trading down 7.13% over the last 24 hours, at $61.39 per share.

Benzinga

Preview: Allied Esports's Earnings

Allied Esports (NASDAQ:AESE) is set to give its latest quarterly earnings report on Wednesday, 2022-05-25. Here's what investors need to know before the announcement. Analysts estimate that Allied Esports will report an earnings per share (EPS) of $-0.08.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Mid-Day Market Update: Dow Drops Over 200 Points; CynergisTek Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

Benzinga

Deutsche Bank Maintains Hold Rating for Zoom Video Comms: Here's What You Need To Know

Deutsche Bank has decided to maintain its Hold rating of Zoom Video Comms (NASDAQ:ZM) and lower its price target from $155.00 to $105.00. Shares of Zoom Video Comms are trading up 5.68% over the last 24 hours, at $94.40 per share.

Benzinga

Benchmark Maintains Buy Rating for Zoom Video Comms: Here's What You Need To Know

Benchmark has decided to maintain its Buy rating of Zoom Video Comms (NASDAQ:ZM) and raise its price target from $124.00 to $128.00. Shares of Zoom Video Comms are trading up 5.68% over the last 24 hours, at $94.40 per share.

Benzinga

Looking Into Zoom Video Comms's Recent Short Interest

Zoom Video Comms's (NASDAQ:ZM) short percent of float has fallen 10.27% since its last report. The company recently reported that it has 9.81 million shares sold short, which is 4.72% of all regular shares that are available for trading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Benzinga

Goldman Sachs Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of Apellis Pharmaceuticals (NASDAQ:APLS) and lower its price target from $94.00 to $84.00. Shares of Apellis Pharmaceuticals are trading down 2.3% over the last 24 hours, at $43.40 per share.

Benzinga

Preview: Change Healthcare's Earnings

Change Healthcare (NASDAQ:CHNG) is set to give its latest quarterly earnings report on Wednesday, 2022-05-25. Here's what investors need to know before the announcement. Analysts estimate that Change Healthcare will report an earnings per share (EPS) of $0.41.

Benzinga

4 Analysts Have This to Say About Iovance Biotherapeutics

Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:

Benzinga

Looking Into Marathon Digital Holdings's Recent Short Interest

Marathon Digital Holdings's (NASDAQ:MARA) short percent of float has risen 9.83% since its last report. The company recently reported that it has 18.77 million shares sold short, which is 20.12% of all regular shares that are available for trading.

Benzinga

Apple Watch With Pride Bands Could Hit Stores This Week

Apple Inc (NASDAQ: AAPL) could release pride editions of Watch bands soon, according to Mark Gurman. What Happened: The tech-focused journalist said on Twitter that the new pride version of the Apple Watch is due for an imminent launch.

Benzinga

As Apple Continues In This Trend, Here's How To Play It Bull And Bear

Apple Inc (NASDAQ: AAPL) opened lower on Tuesday after spiking up 3.86% on Monday in a relief bounce that led the S&P 500 to 1.39% higher.

1 … 445 446 447 448

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.